Drugs / Yueju Pill
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07169916 | Sep 2025 → Dec 2027 expected | biliary tract cancer | Fudan University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yueju Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07169916 ↗ |
| Route | Oral | “6-9 g per dose, twice daily, orally” NCT07169916 ↗ |